M D Pierschbacher

Author PubWeight™ 138.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 New perspectives in cell adhesion: RGD and integrins. Science 1987 18.41
2 Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984 14.25
3 Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 1985 8.55
4 Arg-Gly-Asp: a versatile cell recognition signal. Cell 1986 7.89
5 Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors. Science 1986 5.58
6 Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A 1984 5.13
7 A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci U S A 1985 4.44
8 Amino acid sequence of the human fibronectin receptor. J Cell Biol 1987 4.08
9 Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992 3.96
10 Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Cell 1981 3.64
11 Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci U S A 1983 3.23
12 Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J 1985 2.69
13 The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci U S A 1985 2.64
14 cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci U S A 1986 2.58
15 Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. J Biol Chem 1987 2.29
16 Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol 1985 2.26
17 Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol 1987 2.25
18 A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence. J Cell Biol 1987 2.04
19 The cell attachment domain of fibronectin. Determination of the primary structure. J Biol Chem 1982 2.03
20 Alpha 2 beta 1 integrins from different cell types show different binding specificities. J Biol Chem 1990 1.92
21 Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 1997 1.85
22 Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion. J Biol Chem 1985 1.81
23 Vitronectin--a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res 1985 1.81
24 A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 1993 1.74
25 Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J Cell Biol 1988 1.65
26 cDNA sequences from the alpha subunit of the fibronectin receptor predict a transmembrane domain and a short cytoplasmic peptide. J Biol Chem 1986 1.51
27 An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2. J Cell Biol 1987 1.44
28 Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J Cell Biol 1986 1.42
29 Domain structure of vitronectin. Alignment of active sites. J Biol Chem 1984 1.38
30 Chondroitin/dermatan sulfate proteoglycan in human fetal membranes. Demonstration of an antigenically similar proteoglycan in fibroblasts. J Biol Chem 1984 1.38
31 Calcium as a potential physiological regulator of integrin-mediated cell adhesion. J Biol Chem 1991 1.26
32 Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 1997 1.21
33 Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa. J Biol Chem 1990 1.20
34 Extracellular matrices and cell adhesion. Arteriosclerosis 1985 1.20
35 Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets. Blood 1987 1.20
36 Regulation of alpha 2 beta 1-mediated fibroblast migration on type I collagen by shifts in the concentrations of extracellular Mg2+ and Ca2+. J Cell Biol 1992 1.15
37 T-lymphocyte differentiation and the extracellular matrix: identification of a thymocyte subset that attaches specifically to fibronectin. Proc Natl Acad Sci U S A 1986 1.11
38 Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia. Stroke 2000 1.10
39 Human osteosarcoma cells resistant to detachment by an Arg-Gly-Asp-containing peptide overproduce the fibronectin receptor. J Cell Biol 1987 1.10
40 Preferential expression of fibronectin receptors on immature thymocytes. J Cell Biol 1988 1.07
41 The cell attachment determinant in fibronectin. J Cell Biochem 1985 1.04
42 Purification and characterization of vitronectin. Methods Enzymol 1987 0.99
43 Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response. J Clin Invest 1995 0.98
44 Identification of fibronectin receptors on T lymphocytes. J Cell Biol 1987 0.94
45 Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists. J Med Chem 1994 0.91
46 Concept and progress in the development of RGD-containing peptide pharmaceuticals. Biopolymers 1995 0.90
47 Changes in the concentrations of extracellular Mg++ and Ca++ down-regulate E-cadherin and up-regulate alpha 2 beta 1 integrin function, activating keratinocyte migration on type I collagen. J Invest Dermatol 1995 0.90
48 Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization. Biomaterials 1997 0.88
49 The osteoblast-like differentiated phenotype of a variant of MG-63 osteosarcoma cell line correlated with altered adhesive properties. Connect Tissue Res 1989 0.82
50 A 30 kD sulfated extracellular matrix protein immunologically crossreactive with vitronectin. Matrix 1993 0.80
51 Effects of an arginine-glycine-aspartic acid peptide-containing artificial matrix on epithelial migration in vitro and experimental second-degree burn wound healing in vivo. J Burn Care Rehabil 1997 0.79
52 Role of transforming growth factor beta and decorin in controlling fibrosis. Methods Enzymol 1994 0.78
53 Inhibition of thrombosis by a selective fibrinogen receptor antagonist without effect on bleeding time. Thromb Haemost 1994 0.78
54 Inhibition of coronary artery reocclusion after thrombolysis with an RGD-containing peptide with no significant effect on bleeding time. Coron Artery Dis 1993 0.78
55 Comparison of two phosphoproteins in chicken bone and their similarities to the mammalian bone proteins, osteopontin and bone sialoprotein II. Biochem Biophys Res Commun 1990 0.78
56 In vitro induction of E-rosette formation in human bone marrow cells by the thymic proteins LSHr and LSHh. Immunopharmacology 1979 0.75
57 Biological activity of the pure thymus protein, LSHr. Ann N Y Acad Sci 1979 0.75
58 Therapeutic application of matrix biology. Methods Enzymol 1994 0.75
59 Selective alpha IIb beta 3 receptor blockage with peptide TP9201 prevents platelet uptake on Dacron vascular grafts without significant effect on bleeding time. J Lab Clin Med 1994 0.75